Matches in Wikidata for { <http://www.wikidata.org/entity/Q94445406> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- Q94445406 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q94445406 description "scientific article published on 28 April 2020" @default.
- Q94445406 description "wetenschappelijk artikel" @default.
- Q94445406 description "наукова стаття, опублікована 28 квітня 2020" @default.
- Q94445406 name "Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer: An Open-Label, Dose-Escalation, and Dose-Expansion Phase Ib Trial (REGONIVO, EPOC1603)" @default.
- Q94445406 name "Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer: An Open-Label, Dose-Escalation, and Dose-Expansion Phase Ib Trial (REGONIVO, EPOC1603)" @default.
- Q94445406 type Item @default.
- Q94445406 label "Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer: An Open-Label, Dose-Escalation, and Dose-Expansion Phase Ib Trial (REGONIVO, EPOC1603)" @default.
- Q94445406 label "Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer: An Open-Label, Dose-Escalation, and Dose-Expansion Phase Ib Trial (REGONIVO, EPOC1603)" @default.
- Q94445406 prefLabel "Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer: An Open-Label, Dose-Escalation, and Dose-Expansion Phase Ib Trial (REGONIVO, EPOC1603)" @default.
- Q94445406 prefLabel "Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer: An Open-Label, Dose-Escalation, and Dose-Expansion Phase Ib Trial (REGONIVO, EPOC1603)" @default.
- Q94445406 P1433 Q94445406-1764C153-93BF-4ED0-B20D-530D71D353D0 @default.
- Q94445406 P1476 Q94445406-4118FBD6-DDED-4216-8C6A-EF254A82B801 @default.
- Q94445406 P2093 Q94445406-02E4F3E8-BBD9-45E0-8B90-D8A0DAC06464 @default.
- Q94445406 P2093 Q94445406-042A648D-8FA8-4049-8F55-41E55EDECFC8 @default.
- Q94445406 P2093 Q94445406-0DE4AE29-D128-44B9-804C-680649DCEEB2 @default.
- Q94445406 P2093 Q94445406-14639ACF-0B4C-498C-BEAE-06B79D7B9F27 @default.
- Q94445406 P2093 Q94445406-38480996-5139-40E3-BECF-12D2C6FA183F @default.
- Q94445406 P2093 Q94445406-3C557FDB-B753-4337-B6ED-2231F64CC0F8 @default.
- Q94445406 P2093 Q94445406-77720BA0-A6AA-4AC5-9F8E-2AD52F70ACA4 @default.
- Q94445406 P2093 Q94445406-82B2267D-3CB3-4EB0-9787-FEE8EF00768F @default.
- Q94445406 P2093 Q94445406-91B0E202-27A1-4A04-AD8B-87C34C946E38 @default.
- Q94445406 P2093 Q94445406-A2DE2717-DB8C-40FF-A530-E07F2D64F945 @default.
- Q94445406 P2093 Q94445406-A5E812A3-C697-4C69-915B-4B289BC00F47 @default.
- Q94445406 P2093 Q94445406-AB6849B3-861C-44D4-A370-A8933CA3D225 @default.
- Q94445406 P2093 Q94445406-C6A23974-87A8-41F0-9FA8-C72BA60227F4 @default.
- Q94445406 P2093 Q94445406-D372009B-E5CE-48C2-AACC-458153119ADF @default.
- Q94445406 P2093 Q94445406-EAEA57D2-3452-48AF-ABF1-76A07C459972 @default.
- Q94445406 P2093 Q94445406-F8D78BBD-A7C6-4943-A54C-5B9DDBCA31AE @default.
- Q94445406 P304 Q94445406-EA80ACEC-DF01-48E3-B445-7E7A621CDA99 @default.
- Q94445406 P31 Q94445406-BCDC271D-4A87-4A71-A22B-9A0AB89AFEA1 @default.
- Q94445406 P356 Q94445406-BD3EB1A9-2356-4D7A-8A5A-F31FA8BEC281 @default.
- Q94445406 P50 Q94445406-36A562A5-E387-494D-B762-40D4BECA83BC @default.
- Q94445406 P50 Q94445406-F3F58E88-1A3B-4FFB-A910-7314EA7B3D87 @default.
- Q94445406 P577 Q94445406-E0ACE027-A978-4609-97EA-78AD274C6AEE @default.
- Q94445406 P698 Q94445406-CE7DD997-D8E6-4626-8619-E400A492F281 @default.
- Q94445406 P921 Q94445406-7B03DEFA-248B-4589-A6A4-F46853B70491 @default.
- Q94445406 P356 JCO.19.03296 @default.
- Q94445406 P698 32343640 @default.
- Q94445406 P1433 Q400292 @default.
- Q94445406 P1476 "Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer: An Open-Label, Dose-Escalation, and Dose-Expansion Phase Ib Trial (REGONIVO, EPOC1603)" @default.
- Q94445406 P2093 "Akihiro Sato" @default.
- Q94445406 P2093 "Akihito Kawazoe" @default.
- Q94445406 P2093 "Daisuke Kotani" @default.
- Q94445406 P2093 "Hiroki Hara" @default.
- Q94445406 P2093 "Hiroyoshi Nishikawa" @default.
- Q94445406 P2093 "Hitomi Tamura" @default.
- Q94445406 P2093 "Kohei Shitara" @default.
- Q94445406 P2093 "Masako Asayama" @default.
- Q94445406 P2093 "Masashi Wakabayashi" @default.
- Q94445406 P2093 "Nami Hirano" @default.
- Q94445406 P2093 "Naoki Takahashi" @default.
- Q94445406 P2093 "Shogo Nomura" @default.
- Q94445406 P2093 "Shota Fukuoka" @default.
- Q94445406 P2093 "Takako Yoshii" @default.
- Q94445406 P2093 "Yosuke Togashi" @default.
- Q94445406 P2093 "Yuichi Mikamoto" @default.
- Q94445406 P304 "JCO1903296" @default.
- Q94445406 P31 Q13442814 @default.
- Q94445406 P356 "10.1200/JCO.19.03296" @default.
- Q94445406 P50 Q100481604 @default.
- Q94445406 P50 Q90201608 @default.
- Q94445406 P577 "2020-04-28T00:00:00Z" @default.
- Q94445406 P698 "32343640" @default.
- Q94445406 P921 Q188874 @default.